Status:

UNKNOWN

The International Collaborative Exfoliation Syndrome Treatment Study

Lead Sponsor:

The New York Eye & Ear Infirmary

Collaborating Sponsors:

Pfizer

Conditions:

Exfoliation Syndrome

Glaucoma

Eligibility:

All Genders

50-80 years

Phase:

NA

Brief Summary

Purpose: To determine the efficacy of treatment with latanoprost in combination with pilocarpine versus timolol or timolol/dorzolamide fixed combination (Timoptic or Cosopt) in eyes with XFS and eleva...

Detailed Description

Purpose: To compare the effect of treatment with latanoprost plus pilocarpine vs timolol or fixed combination timolol/dorzolamide (T/D) in eyes with exfoliation syndrome (XFS) and elevated IOP. Metho...

Eligibility Criteria

Inclusion

  • Exfoliation syndrome in one or both eyes. Exfoliation material must be present on the anterior lens surface for diagnosis.
  • Untreated IOP greater than or equal to 22 mmHg in one or both eyes with or without mild to moderate glaucomatous damage and who, in the judgment of the investigator, can be safely washed off from current medical therapy.
  • Age 50-80 years
  • Open angles by gonioscopy

Exclusion

  • Age over 80 years
  • Best corrected visual acuity less than 20/30
  • Untreated IOP greater than 35 mmHg
  • Currently taking systemic beta-blockers
  • Glaucomatous damage sufficiently severe to prevent washout in the opinion of the examiner or visual field defect within 10 degrees of fixation
  • Glaucoma other than exfoliation syndrome
  • Absence of exfoliation material on the lens surface in the eye to be treated
  • Known allergy or sensitivity to any of the study medications
  • Ocular pathology that may interfere with the ability to obtain tonography, visual fields, or accurate IOP readings
  • Angle-closure glaucoma
  • Diabetic retinopathy
  • Previous intraocular or laser surgery.
  • Unwilling or unable to give consent
  • Pregnant or lactating women

Key Trial Info

Start Date :

August 1 2000

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2008

Estimated Enrollment :

277 Patients enrolled

Trial Details

Trial ID

NCT00804115

Start Date

August 1 2000

End Date

December 1 2008

Last Update

December 8 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

New York Eye and Ear Infirmary

New York, New York, United States, 10003